Book chapters

This content aligns with Goal 3: Good Health by addressing innovative treatment options for multiple sclerosis (MS), specifically hematopoietic stem cell transplantation (HSCT), which may offer hope for patients with aggressive forms of the disease and improve their chances of long-term remission. By discussing the efficacy, safety, and unique considerations of HSCT, the chapter emphasizes the importance of personalized treatment approaches in enhancing health outcomes for individuals with MS. Furthermore, it supports Goal 10: Reduced Inequalities by providing insights into advanced therapies and recommendations for patient selection, which can help ensure that all patients, regardless of their background, have access to cutting-edge treatments that can significantly impact their quality of life and manage their condition effectively.